Authors: A. Jirkovská 1; R. Bém 1; K. Novotný 2; Řezaninová L.i; K. Cechová 1 Authors‘ workplace: Centrum diabetologie Institutu klinické a experimentální medicíny, Praha Přednosta : prof. MUDr. Terezie Pelikánová, DrSc. 1; Kardiochirurgická klinika 2. LF UK a Fakultní nemocnice Motol, Praha Přednosta: prof. MUDr. Ivan Vaněk, DrSc. 2 Published in: Prakt. Lék. 2007; 87(9): 559-563 Category: Case Report
Debridement is an essential component of wound care as necrotic tissue can impede the healing process. Larval therapy (biosurgery) is a promising addition to a whole spectrum of treatment methods. The main indication for maggot therapy is to disinfect and clean necrotic and infected wounds – e.g. diabetic foot disease (including amputation sites), venous leg ulcers, necrotising fasciitis, traumatic wounds, primary burns, pressure sores. Some evidence, while anecdotal, supports the use of larval therapy against wounds pathogens such as methicillin-resistant Staphylococcus aureus (MRSA) infection. No serious side-effects of this therapy have been observed when appropriately indicated. An overview of the benefits of larval therapy is presented, along with the results of our first practical experiences.
Key words: larval therapy, diabetic foot disease, maggots, debridement
Don‘t have an account? Create new account
Enter the email address that you registered with. We will send you instructions on how to set a new password.
